Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (41-50 of 265) with videos related to

Pageof 27
Sort By:
La Radiologia Medica|May 13, 2016
Foci on breast magnetic resonance imaging in high-risk women: cancer or not?Paola Clauser, Enrico Cassano, Arianna De Nicolò, et al.
International Journal of Surgical Oncology|December 5, 2012
Breast ductal carcinoma in situVirgilio Sacchini, Lucio Fortunato, Hiram S Cody Iii, et al.
JNCI Cancer Spectrum|February 8, 2021
Response to BraillonBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy usersGabriella Rondanina, Matteo Puntoni, Gianluca Severi, et al.
Cancer Treatment Reviews|March 7, 2017
Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's boxMatteo Lazzeroni, Barbara K Dunn, Giancarlo Pruneri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2015
Difficult choices for young patients with cancer: the supportive role of decisional counselingLeonora Chiavari, Sara Gandini, Irene Feroce, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2017
A Survey among Breast Cancer Specialists on the Low Uptake of Therapeutic Prevention with Tamoxifen or RaloxifeneSilvia Noonan, Ambra Pasa, Vincenzo Fontana, et al.
Breast Cancer Research and Treatment|November 13, 2004
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancerHarriet Johansson, Laura Baglietto, Aliana Guerrieri-Gonzaga, et al.
Cancer Research|November 18, 2008
Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancerHarriet Johansson, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Pageof 27

Showing results (41-50 of 265) with videos related to

Sort By:
Pageof 27
La Radiologia Medica|May 13, 2016
Foci on breast magnetic resonance imaging in high-risk women: cancer or not?Paola Clauser, Enrico Cassano, Arianna De Nicolò, et al.
International Journal of Surgical Oncology|December 5, 2012
Breast ductal carcinoma in situVirgilio Sacchini, Lucio Fortunato, Hiram S Cody Iii, et al.
JNCI Cancer Spectrum|February 8, 2021
Response to BraillonBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy usersGabriella Rondanina, Matteo Puntoni, Gianluca Severi, et al.
Cancer Treatment Reviews|March 7, 2017
Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's boxMatteo Lazzeroni, Barbara K Dunn, Giancarlo Pruneri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2015
Difficult choices for young patients with cancer: the supportive role of decisional counselingLeonora Chiavari, Sara Gandini, Irene Feroce, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2017
A Survey among Breast Cancer Specialists on the Low Uptake of Therapeutic Prevention with Tamoxifen or RaloxifeneSilvia Noonan, Ambra Pasa, Vincenzo Fontana, et al.
Breast Cancer Research and Treatment|November 13, 2004
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancerHarriet Johansson, Laura Baglietto, Aliana Guerrieri-Gonzaga, et al.
Cancer Research|November 18, 2008
Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancerHarriet Johansson, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Pageof 27